| GA23319-005mg |
|
1926163-80-5 |
Octreotide trifluoroacetate salt (Dimer, Parallel)
|
0 |
C98H132N20O20S4 |
|
|
|
| GA23318-1mg |
|
1926163-78-1 |
Octreotide trifluoroacetate salt (Dimer, Antiparallel)
|
0 |
C98H132N20O20S4 |
|
|
|
| GA23318-005mg |
|
1926163-78-1 |
Octreotide trifluoroacetate salt (Dimer, Antiparallel)
|
0 |
C98H132N20O20S4 |
|
|
|
| GA23317-1g |
|
156825-89-7 |
Octadecylphosphophosphoniumcholine
|
0 |
C23H50O4P2 |
|
|
|
| GA23317-250mg |
|
156825-89-7 |
Octadecylphosphophosphoniumcholine
|
0 |
C23H50O4P2 |
|
|
|
| GA23317-100mg |
|
156825-89-7 |
Octadecylphosphophosphoniumcholine
|
0 |
C23H50O4P2 |
|
|
|
| GA23316-5mg |
|
148796-86-5 |
|
0 |
C48H98N32O9 |
|
|
|
| GA23316-1mg |
|
148796-86-5 |
|
0 |
C48H98N32O9 |
|
|
|
| GA23315-1g |
|
189302-40-7 |
N-ω-Hydroxy-L-norarginine
|
0 |
C5H12N4O3 |
|
|
|
| GA23315-250mg |
|
189302-40-7 |
N-ω-Hydroxy-L-norarginine
|
0 |
C5H12N4O3 |
|
|
|
| GA23315-50mg |
|
189302-40-7 |
N-ω-Hydroxy-L-norarginine
|
0 |
C5H12N4O3 |
|
|
|
| GA23314-5g |
|
24123-14-6 |
|
0 |
C4H10N2O2 |
|
|
|
| GA23314-1g |
|
24123-14-6 |
|
0 |
C4H10N2O2 |
|
|
|
| GA23313-5g |
|
24123-04-4 |
N-β-Aminoethyl-Gly-OEt . 2 HCl
|
0 |
C6H14N2O2 · 2HCl |
|
|
|
| GA23313-1g |
|
24123-04-4 |
N-β-Aminoethyl-Gly-OEt . 2 HCl
|
0 |
C6H14N2O2 · 2HCl |
|
|
|
| GA23312-100g |
|
19327-38-9 |
|
0 |
C14H30O4 |
|
|
|
| GA23312-25g |
|
19327-38-9 |
|
0 |
C14H30O4 |
|
|
|
| GA23312-5g |
|
19327-38-9 |
|
0 |
C14H30O4 |
|
|
|
| GA23311-100g |
|
19327-39-0 |
|
0 |
C16H34O5 |
|
|
|
| GA23311-25g |
|
19327-39-0 |
|
0 |
C16H34O5 |
|
|
|
